Last month, the Institute for Clinical and Economic Review (ICER) issued a draft report on the cost-effectiveness of bluebird bio’s lovo-cel (lovotibeglogene autotemcel) and Vertex/CRISPR’s ...

Sanofi and Regeneron's next-gen cholesterol drug Praluent never lived up to early expectations, and its price tag was at least partly to blame. The cost petrified payers. Even before it—and its fellow ...

A new report from the Institute for Clinical and Economic Review (ICER) in the US has found that the net prices of newly launched drugs rose 51% in a three-year period between 2022 and 2024, while the ...

Just five days after releasing a 145-page draft report suggesting that three next-generation treatments for rheumatoid arthritis would be unlikely to be cost-effective, the Institute for Clinical and ...

NEW YORK, Feb. 24, 2020 /PRNewswire/ -- Today, the Institute for Clinical and Economic Review (ICER) announced it has selected Aetion as a preferred partner and platform to generate decision-grade ...

The Institute for Clinical and Economic Review (ICER) is sometimes called America's `NICE,’ referring to the National Institute for Health and Care Excellence in England and Wales. In certain ways, ...

Please provide your email address to receive an email when new articles are posted on . Patient experts expressed excitement over ensifentrine’s ability to lower exacerbations. If priced between ...

With the US Institute for Clinical and Economic Review (ICER) looking like it is here to stay, Leela Barham considers how its value framework is evolving. The US Institute for Clinical and Economic ...

Pharma doesn’t seem to know what to do with — or about — the Institute for Clinical and Economic Review (ICER). On one hand, nearly everyone in the healthcare ecosystem agrees on the need for a more ...

As part of its national formulary management process, the Department of Veterans Affairs (VA) Pharmacy Benefits Management Services (PBM) critically evaluates published, peer-reviewed articles on ...